Sneha S. Kelkar is a Scientist in Real-World Evidence & Data Analytics and Strategic Market Access, located in Pharmerit’s New York office. Her expertise includes literature reviews, clinical trial analyses, large retrospective database/claims analyses, electronic medical data analyses, patient chart reviews, physician surveys, indirect treatment comparisons and budget impact models. She has over 6 years of experience conducting health economics and outcomes research in therapeutic areas such as oncology, immunology, gastroenterology, rheumatology, neurology, psychiatry and other chronic conditions.
Prior to joining Pharmerit, she worked with Analysis Group in New York and has conducted numerous studies involving targeted and systematic reviews and meta-analysis, burden of illness, treatment pattern analysis, cost and resource utilization and epidemiological outcomes. Her research has been presented in international conferences and published in peer-reviewed journals. She holds a Bachelor of Science in Industrial Microbiology and a Master of Science in Health Sciences from Pune, India. She received a Masters in Public Health – Epidemiology from Columbia University, New York.